There are a handful of companies that dominate the coronavirus vaccine market. Vaccine hesitancy prevents many people from getting inoculated. One company looking to make headway into the vaccine-hesitant crowd is Vaxart (NASDAQ: VXRT).
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting